Galena Biopharma Reports Second Quarter 2015 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. STZ
5. CRBU
6. SKYD
7. BBIO
8. OPCH
9. NEOG
10. HALO

Go back to Galena Biopharma Reports Second Quarter 2015 Financial Results

Galena Biopharma (GALE) Misses Q2 EPS by 1c

August 6, 2015 4:55 PM EDT

Galena Biopharma (NASDAQ: GALE) reported Q2 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $3.38 million versus the consensus estimate of $3.54 million.

"With our balance sheet strengthened, we made significant clinical progress in the second quarter as we reached a critical milestone with completion of enrollment in our Phase 3 PRESENT trial and had... More